Jefferies Sees Takeover of St. Jude Medical (STJ)

Jefferies & Co analyst, Mark Richter, comments on St. Jude Medical (NYSE: STJ), "We would be buyers at current levels. We believe that STJ's valuation is attractive and that business fundamentals are intact. Furthermore, we continue to expect ICD market recovery in 2007 and believe STJ is a viable acquisition target in the next 12 months."